{"document_type": "article", "byline": {"contributor": "Sabrina Tavernise contributed reporting.", "person": [{"role": "reported", "firstname": "Katie", "organization": "", "rank": 1, "lastname": "THOMAS"}], "original": "By KATIE THOMAS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Food and Drug Administration is probing whether faulty blood-testing machine may have compromised results of clinical trial leading to approval of Johnson & Johnson's anticlotting drug Xarelto; will seek to understand whether warning signs were apparent to drug maker. ", "multimedia": [{"type": "image", "url": "images/2016/02/23/business/23DRUG/23DRUG-thumbWide.jpg", "legacy": {"wide": "images/2016/02/23/business/23DRUG/23DRUG-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/02/23/business/23DRUG/23DRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2016/02/23/business/23DRUG/23DRUG-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "405"}, "width": 600, "subtype": "xlarge", "height": 405}, {"type": "image", "url": "images/2016/02/23/business/23DRUG/23DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/02/23/business/23DRUG/23DRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "F.D.A. Seeks New Details in Approval of Xarelto   ", "main": "F.D.A. Asks If Faulty Blood Monitor Tainted Xarelto Approval"}, "print_page": "1", "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Johnson & Johnson", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Blood Clots", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Clinical Trials", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Recalls and Bans of Products", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Bayer AG", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "European Medicines Agency", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Alere Inc", "is_major": "N", "rank": "9", "name": "organizations"}], "snippet": "A legal brief says Johnson & Johnson has been asked whether Alere\u2019s recalled INRatio blood-testing monitor compromised the anticlotting drug\u2019s trial.", "source": "The New York Times", "lead_paragraph": "A legal brief says Johnson & Johnson has been asked whether Alere\u2019s recalled INRatio blood-testing monitor compromised the anticlotting drug\u2019s trial.", "word_count": "1420", "pub_date": "2016-02-23T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/02/23/business/fda-asks-if-faulty-blood-monitor-tainted-xarelto-approval.html", "_id": "56cb994338f0d80fb3eb22f1"}